Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Bernard

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
The European Journal of Medicine|October 1, 1993
Treatment of multiple myeloma with etidronate: results of a multicentre double-blind study. Groupe d'Etudes et de Recherches sur le Myélome (GERM)A Daragon, C Humez, C Michot, et al.
American Journal of Hematology|February 1, 1995
Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)T Facon, J F Menard, J L Michaux, et al.
La Revue De Medecine Interne|January 1, 1993
[Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums]C Mathiot, B Grosbois, J L Teillaud, et al.
Journal of Clinical Immunology|January 1, 1993
Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myelomaC Mathiot, J L Teillaud, M Elmalek, et al.
La Revue De Medecine Interne|January 1, 1990
[IgM myeloma: 6 cases and a review of the literature]A De Gramont, B Grosbois, J L Michaux, et al.
British Journal of Haematology|February 1, 1992
VAD or VMBCP in severe multiple myeloma. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)M Monconduit, J F Menard, J L Michaux, et al.
British Journal of Haematology|May 10, 2006
High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II studyL Mannone, C Gardin, M C Quarre, et al.
British Journal of Haematology|November 25, 1998
VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide-prednisone therapy (protocol MY 85)P Mineur, J F Ménard, X Le Loët, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
The European Journal of Medicine|October 1, 1993
Treatment of multiple myeloma with etidronate: results of a multicentre double-blind study. Groupe d'Etudes et de Recherches sur le Myélome (GERM)A Daragon, C Humez, C Michot, et al.
American Journal of Hematology|February 1, 1995
Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)T Facon, J F Menard, J L Michaux, et al.
La Revue De Medecine Interne|January 1, 1993
[Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums]C Mathiot, B Grosbois, J L Teillaud, et al.
Journal of Clinical Immunology|January 1, 1993
Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myelomaC Mathiot, J L Teillaud, M Elmalek, et al.
La Revue De Medecine Interne|January 1, 1990
[IgM myeloma: 6 cases and a review of the literature]A De Gramont, B Grosbois, J L Michaux, et al.
British Journal of Haematology|February 1, 1992
VAD or VMBCP in severe multiple myeloma. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)M Monconduit, J F Menard, J L Michaux, et al.
British Journal of Haematology|May 10, 2006
High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II studyL Mannone, C Gardin, M C Quarre, et al.
British Journal of Haematology|November 25, 1998
VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide-prednisone therapy (protocol MY 85)P Mineur, J F Ménard, X Le Loët, et al.
Pageof 9